The topic of this blog will not be the coronavirus (surprisingly), but rather, a monoclonal antibody drug called Reopro, or Abciximab. (Abciximab is way too hard to write over and over so I’m just going to call it Reopro). However, before I get into the specifics of this drug, what exactly is a monoclonal antibody? According to Medicinenet.com, monoclonal antibodies are synthetic antibodies, generally made in mice, that function like normal antibodies by protecting humans against one specific pathogen. Basically, the ‘mono’ stands for ‘one,’ the ‘clonal’ for the fact that they are clones, and antibody for, well, its pretty obvious.
Moving on to Reopro, what does this specific monoclonal antibody do? Well, you’re in luck, because I’m about to tell you. According to its manufacturer, Reopro is used to prevent complications when people have percutaneous coronary intervention, otherwise known as heart surgery. By “prevent complications” I mean it keeps the patient from developing blood clots. Reopro is essentially a blood thinner that works by binding to a receptor on platelets (called a glycoprotein IIb/IIIa receptor) and preventing them from clotting. Because this is a blood thinner, it does come along with possible bleeding-related side effects, including:
- internal bleeding
- GI/GU bleeding
- cerebrovascular accident
- bleeding diathesis
- thrombocytopenia
- Intracranial neoplasm
- arteriovenous malformation
- aneurysm
- hypertension
- allergic reaction
Essentially, this drug can make you bleed when you shouldn’t because it thins your blood. However, considering the side effects of ‘complications’ of percutaneous coronary intervention (including heart attack and death) it seems like it is worth the risk to take it. Additionally, none of the articles I read mentioned anything about this drug impacting the innate or acquired immune system. (Though its desired effect of lowering platelet clumping does interfere with the innate ability to prevent bleeding). I did not read anything about this drug increasing susceptibility to another pathogen either. On the whole, it seems like a desirable option for preventing blood clots.
